Telehealth platforms in senators’ crosshairs over Eli Lilly, Pfizer offers
On Tuesday, a gaggle of senators despatched letters to 5 telehealth corporations that supply care by means of direct-to-consumer portals from pharmaceutical producers Pfizer and Eli Lilly, interrogating their monetary relationships. The questions search to find out whether or not contracts between pharma and telehealth corporations might violate the federal anti-kickback statute.
The group of senators led by Sen. Dick Durbin (D-In poor health.) in October despatched comparable letters to Pfizer and Eli Lilly demanding solutions about their relationships with the telehealth prescribers, which sufferers can entry by means of web sites PfizerForAll and LillyDirect, which additionally supply sufferers the power to fill prescriptions for his or her drugs on-line.
“After describing Pfizer’s drugs and the profit they will have for sufferers, Pfizer’s telehealth platform supplies a hyperlink for sufferers to “speak to a health care provider now” and fill prescriptions through a web based pharmacy,” the senators write of their letter to UpScript Well being, which supplies telehealth platforms to a number of pharmaceutical producers. “This creates the impression that any affected person focused on a selected remedy can certainly obtain it with just some clicks, and the looks of Pfizer’s approval that these chosen telehealth suppliers can guarantee a affected person receives the given remedy.”
This text is unique to STAT+ subscribers
Unlock this text — and get further evaluation of the applied sciences disrupting well being care — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
